Tucson, Arizona (PRWEB) November 27, 2013
Tucson, Arizona should be on any bioscience or biotechnology company’s short list for relocation or expansion, according to a white paper issued by ITRA Global affiliate Commercial Real Estate Group of Tucson LLC.
The nine-page report, “The Bio Industry in Tucson, Arizona,” points out that several bioscience companies already thrive in the region, including Ventana Medical Systems, Sanofi and SynCardia Systems. It also mentions that Accelerate Diagnostics moved from Denver to Tucson in 2012.
“I was impressed from my first contacts with Pima County, the Tucson mayor’s office, the state of Arizona and the Tucson Regional Economic Opportunities Office,” Accelerate President and CEO, Lawrence Mehren, is quoted as saying in the white paper. “We could tell this was a place that valued our businesses and wanted to help.”
“Proximity to large private enterprises in bioscience is only one of the reasons Tucson is a rising biotechnology star,” says Michael Coretz, principal of Commercial Real Estate Group of Tucson / ITRA Global. “Our city also boasts available venture capital, an encouraging spirit of entrepreneurship and a strong research community, including the University of Arizona’s Bio5 Institute.”
The availability of federal and state government funding and a highly skilled workforce are other reasons Tucson, the hub of Southern Arizona, should get prime consideration by biotechnology and bioscience firms, the report says.
Commercial Real Estate of Tucson is the Tucson Affiliate of ITRA Global and Michael Coretz is a site selection expert
Copyright©2012 Vocus, Inc.
All rights reserved